Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment-Reference-Cited by-同舟云学术

Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment

Published:2013-09-24 Issue:1 Volume:17 Page:129-146
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Ardelean Daniela S.,Jerkic Mirjana,Yin Melissa,Peter Madonna,Ngan Bo,Kerbel Robert S.,Foster F. Stuart,Letarte Michelle

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-013-9383-4.pdf

Reference66 articles.

1. Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24(6):203–219. doi: 10.1016/j.blre.2010.07.001

2. Dupuis-Girod S, Bailly S, Plauchu H (2010) Hereditary hemorrhagic telangiectasia: from molecular biology to patient care. J Thromb Haemost 8(7):1447–1456. doi: 10.1111/j.1538-7836.2010.03860.x

3. Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43(2):97–110. doi: 10.1136/jmg.2005.030833

4. Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jais X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O’Callaghan DS, Simonneau G, Soubrier F, Humbert M (2010) Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 181(8):851–861. doi: 10.1164/rccm.200908-1284OC

5. Mache CJ, Gamillscheg A, Popper HH, Haworth SG (2008) Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1. Thorax 63(1):85–86. doi: 10.1136/thx.2007.076109

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances;Journal of Clinical Investigation;2024-02-15

2. Therapeutic Targeting of the Ang2/Tie Pathway in Endothelial Cells as a Potential Treatment of Hereditary Hemorrhagic Telangiectasia;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-08

3. ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-08

4. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?;European Journal of Medical Genetics;2022-10

5. Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia;Journal of Clinical Medicine;2020-11-05